|
|
|
28.04.26 - 01:18
|
KBRA Assigns Preliminary Ratings to J.P. Morgan Mortgage Trust 2026-LTV1 (JPMMT 2026-LTV1) (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--#creditratingagency--KBRA assigns preliminary ratings to 8 classes of mortgage pass-through notes from J.P. Morgan Mortgage Trust 2026-LTV1 (JPMMT 2026-LTV1). JPMMT 2026-LTV1 is a prime high LTV RMBS transaction sponsored by JPMorgan Chase Bank, National Association and comprises 382 residential mortgages with an aggregate unpaid principal balance (UPB) of approximately $318.9 million as of the April 1, 2026, cut-off date. The underlying collateral consists primarily of 30-year fixed-rate mortgages (FRMs) and adjustable-rate mortgages (ARMs) and includes both non-agency (96.7%) and agency-eligible (3.3%) loans. JPMMT 2026-LTV1 utilizes a Pro Rata/Sequential Hybrid structure.
KBRA's rating approach incorporated loan-level analysis of the mortgage pool through its Residential Asset Loss Model (REALM), an examination of the results from third-party loan file due diligence, cash flow modeling analysis of the transaction's payment structure, reviews of key transaction parties and a...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
24.04.26 - 19:09
|
Jane Street Made A Record $40 Billion In Trading Revenue Last Year, More Than All Wall Street Banks (ZeroHedge)
|
|
|
Jane Street Made A Record $40 Billion In Trading Revenue Last Year, More Than All Wall Street Banks
The 10am slam in bitcoin, which we documented virtually every days since 2024 may have ended once Jane Street got busted for insider trading in the Terraform collapse, but that doesn't mean that the Wall Street HFT trading giant slowed down. On the contrary: according to Bloomberg, Jane Street Group reeled in a Wall Street record $39.6 billion of trading revenue last year, more than any Wall Street bank.
According to the report, the firm beat out all global investment banks after reaping $15.5 billion in the year's final quarter, and with only 3,500 employees, it beat nearest rival JPMorgan by 11% during the year. The company's adjusted ETBIDA for the full year was a stunning $31.2 billion.
While Jane Street's profits were lifted by surging valuations of its stakes in privately held companies, the firm's main business matching buyers and sellers across assets thrived on bouts of market v...
|
|
|
24.04.26 - 18:06
|
JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point? (24/7 Wall St.)
|
|
|
Hims & Hers Health (NYSE:HIMS) just picked up a high-profile endorsement. JPMorgan analyst Cory Carpenter initiated coverage with an Overweight rating and a $35 price target, framing the telehealth platform's recent Novo Nordisk (NYSE:NVO) partnership as a potential “turning point” for the business. The call lands with HIMS stock trading at $30.46. For long-term investors, ... JPMorgan Initiates Hims & Hers With Overweight: Could the Novo Nordisk Deal Be the Turning Point?...
|
|
|
|
|
|
|
|
|
|
|
24.04.26 - 13:06
|
A $900,000 Stock Portfolio Exposed to Just Three Sectors Is a Retirement Time Bomb (24/7 Wall St.)
|
|
|
At 63, with $900,000 in a brokerage account split across tech (45%), healthcare (30%), and financials (25%), you have built something real. The five holdings — Apple (NASDAQ:AAPL), Microsoft (NASDAQ:MSFT), Johnson & Johnson (NYSE:JNJ), UnitedHealth Group (NYSE:UNH), and JPMorgan Chase (NYSE:JPM) — are legitimate blue-chip businesses. The problem is what happens to all three sectors ... A $900,000 Stock Portfolio Exposed to Just Three Sectors Is a Retirement Time Bomb...
|
|
|
|
|
|